Proviron

DRAGON PHARMA PROVIRON

Proviron, the brand name for mesterolone, is an oral androgen and anabolic steroid. It is a derivative of dihydrotestosterone and is known for its unique properties, including acting as an androgen receptor antagonist in certain tissues.

DRUG COMPOSITION

The active ingredient in Proviron is mesterolone. Each tablet is carefully formulated to contain a specific dosage of mesterolone, and the pharmaceutical composition may vary between manufacturers.

LAB TEST REPORT

PHARMACEUTICAL FORM

Proviron is commonly available in the form of oral tablets. These tablets are typically round and may be scored to facilitate ease of dosage adjustment. The color and shape of the tablets can vary.

PHARMACEUTICAL GROUP AND ATC CODE

Proviron belongs to the pharmacotherapeutic group of anabolic steroids, specifically the subgroup of androgens. It is not assigned a unique Anatomical Therapeutic Chemical (ATC) code.

PHARMACOLOGICAL PROPERTIES

Mesterolone exhibits androgenic and anabolic effects, making it useful in certain medical conditions. Its unique property as an androgen receptor antagonist in specific tissues sets it apart from other steroids.

PROFILE

• Chemical name: 1О±-Methyl-17ОІ-hydroxy-[5О±]-androstan-3-one
• Chemical formula: C20H32O2
• Percentage of anabolic activity: 150.00%
• Percentage of androgenic activity: 40.00%
• Active half life: 12 hours
• Recommended dosage: 25-100 mg/day
• Acne: yes
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: low
• Aromatization: no

THERAPEUTICAL INDICATIONS

Proviron is indicated in the treatment of various androgen deficiencies, including male infertility and hypogonadism. It may also be used to support spermatogenesis and enhance androgen levels.

DOSES AND METHOD OF ADMINISTRATION

The dosage of Proviron varies depending on the medical condition being treated. In non-medical contexts, bodybuilders and athletes may use doses ranging from 25 to 150 mg per day. The drug is typically administered orally.

CYCLE/STACKING

An example of a Proviron cycle may involve its use as an adjunct to anabolic steroid cycles. It is often used to mitigate estrogenic side effects and enhance the androgenic profile of the cycle.

POST CYCLE THERAPY

Post-cycle therapy after Proviron use is not a common practice, as Proviron does not significantly suppress the body's natural testosterone production. However, individual circumstances may vary.

SIDE EFFECTS

While generally well-tolerated, Proviron may cause side effects such as androgenic effects (acne, hair loss) and alterations in lipid profiles. Monitoring for potential side effects is advisable during use.

CONTRAINDICATIONS

Contraindications for Proviron use include hypersensitivity to mesterolone, prostate cancer, and breast cancer. Caution is advised in individuals with liver dysfunction.

OVERDOSE

An acute overdose with Proviron may lead to an exacerbation of side effects. Immediate medical attention is recommended if overdose is suspected.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Special precautions are necessary for individuals with pre-existing conditions such as hepatic impairment. Regular medical check-ups are advisable during prolonged use.

INTERACTIONS WITH OTHER DRUGS

Proviron may interact with certain medications, including anticoagulants. Informing healthcare professionals of all medications in use is crucial.

PRESENTATION, PACKAGING

100 tablets in sachet.

STORAGE

Proviron tablets should be stored in a cool, dry place away from direct sunlight. Adherence to recommended storage conditions is essential for maintaining the drug's stability.

DELIVERY TO THE USA

Proviron is available for secure and discreet delivery to the USA through authorized supplier - Steroid.biz.

LEGAL STATUS

Proviron is subject to regulations concerning its possession, distribution, and use. Compliance with local laws and regulations is necessary.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Mesterolone Wiki, wikipedia.org
• Mesterolone | C20H32O2 | CID 15020, pubchem.ncbi.nlm.nih.gov.